Bayview Pharmacy is pleased to present a specially compounded topical cream containing Montelukast 1%, Naltrexone HCl 0.5%, and Ketotifen 0.05%. This unique formulation is specifically designed to address a range of skin conditions, such as eczema, psoriasis, and atopic dermatitis.

The active ingredients in this cream work synergistically to alleviate the symptoms of these skin conditions. Montelukast, an anti-inflammatory agent, helps to reduce inflammation and itching, providing relief from the discomfort associated with these skin conditions. Naltrexone HCl, an opioid antagonist, aids in reducing the sensation of pain and itching, further enhancing the comfort of the user. Lastly, Ketotifen, an antihistamine, helps to decrease the production of histamine, a compound that can cause itching and inflammation.

This combination of medications in a semisolid preparation dispensed in a pump mechanism allows for convenient and controlled application on the skin. It is designed for localized treatment, ensuring that the active ingredients are absorbed precisely where they are needed. This formulation is intended to reduce inflammation, itching, and pain associated with various skin conditions, providing relief and improving the quality of life for those affected.

However, it is crucial to note that this formulation should not be applied to broken or infected skin. Always consult with a healthcare professional before starting any new treatment regimen.

If you have any questions about this formulation or how it can assist in treating your skin condition, please do not hesitate to contact us. Our team is committed to helping you find the most effective treatment options for your specific needs.

Montelukast 1%/Naltrexone HCl 0.5%/Ketotifen 0.05% Topical Cream is a compounded formulation designed for the treatment of various inflammatory skin conditions such as atopic dermatitis and psoriasis. This semisolid preparation is dispensed in a pump mechanism for convenient and controlled application on the skin, allowing for localized treatment and absorption of the active ingredients.

The cream contains Montelukast, an anti-inflammatory agent that helps reduce itching and inflammation associated with these conditions. Naltrexone HCl, an opioid antagonist, is also included in the formulation to help alleviate itching and inflammation. Additionally, the cream contains Ketotifen, an antihistamine that further aids in reducing itching and inflammation.

When using this topical cream, it is crucial to be aware of potential drug interactions. Montelukast may interact with other medications such as anticoagulants, anticonvulsants, and immunosuppressants. Naltrexone HCl may interact with opioids, alcohol, and benzodiazepines. Ketotifen may interact with anticholinergics, antihistamines, and anticonvulsants. Always consult with your healthcare provider or pharmacist before starting any new medication.

Common side effects associated with Montelukast 1%/Naltrexone HCl 0.5%/Ketotifen 0.05% Topical Cream may include skin irritation, burning, stinging, and redness. If any of these side effects occur, it is important to contact your healthcare provider immediately. Always use this medication as directed by your healthcare provider and report any unusual or severe side effects promptly.

If you have any questions about Montelukast 1%/Naltrexone HCl 0.5%/Ketotifen 0.05% Topical Cream, its potential interactions, or side effects, please consult with your healthcare provider or pharmacist. They can provide you with the most accurate and up-to-date information based on your specific health situation and medication regimen.

Montelukast 1%/Naltrexone HCl 0.5%/Ketotifen 0.05% Topical Cream is a specially compounded medication designed to address a range of skin conditions. This unique formulation combines the anti-inflammatory properties of Montelukast, the opioid antagonist effects of Naltrexone HCl, and the antihistamine benefits of Ketotifen. Together, these active ingredients work synergistically to alleviate inflammation, itching, and redness associated with various skin conditions.

Montelukast functions by inhibiting the action of leukotrienes, chemicals that trigger inflammation. Naltrexone HCl, an opioid antagonist, operates by blocking opioid receptors, thereby reducing itching and redness. Ketotifen, an antihistamine, works by obstructing the action of histamine, further reducing itching and redness.

The Montelukast 1%/Naltrexone HCl 0.5%/Ketotifen 0.05% Topical Cream is dispensed in a pump mechanism for easy and controlled application. It is designed for localized treatment, allowing for targeted application on the skin. The cream should be applied to the affected area twice daily, or as directed by your healthcare provider. It is crucial to avoid contact with the eyes, nose, and mouth when applying the cream. In case of accidental contact, rinse the area thoroughly with water.

This compounded cream is effective in treating a variety of skin conditions, including eczema, psoriasis, and contact dermatitis. It can also be used to alleviate itching and redness associated with insect bites and stings. Always consult with your healthcare provider for proper usage and application instructions.

If you have any questions or need further information about the Montelukast 1%/Naltrexone HCl 0.5%/Ketotifen 0.05% Topical Cream, please do not hesitate to reach out. Our team of compounding pharmacists is here to assist you.

This compounded formulation of Montelukast 1%/Naltrexone HCl 0.5%/Ketotifen 0.05% is a semisolid preparation dispensed in a pump mechanism. It is designed for convenient and controlled application on the skin, allowing for localized treatment or absorption of the active ingredients. This topical cream is primarily indicated for the treatment of Atopic Dermatitis, Allergic Rhinitis, Asthma, Urticaria, and Pruritus. It is crucial to understand that this formulation is not intended for the treatment of any other conditions.

It is not recommended for use in children under the age of 12. Patients are advised to apply a thin layer of the cream to the affected area twice daily, or as directed by their healthcare provider. This formulation should not be used on broken or irritated skin. In case of any adverse reactions, patients should immediately contact their healthcare provider.

Patients should also be cautious to avoid contact with the eyes, nose, and mouth when applying this formulation. If contact occurs, it is important to rinse thoroughly with water. For any queries or concerns regarding this formulation, patients are encouraged to consult their healthcare provider.